Caligan Partners将支持以每股至少3美元的价格出售该公司。潜在的购买方可能包括CSL Behring(OTCPK:CSLY)、Grifols(纳斯达克:GRFS)、武田夏尔和Octaharma。私募股权机构也可能对公司感兴趣。
查看全文
智通财经APP了解到,低价股虽然波动很大,但可能成为投资组合中有吸引力的补充部分。 尽管今年美股大幅下滑,但一些低价生物科技股实现了三位数涨幅。具体如下: ADMA Biologics 对ADMA Biologics(ADMA.US)来说,今年是丰收的一年,其股... 网页链接
$Adma生物制品(ADMA)$ 8-K - Current report Filed: 2019-04-02 AccNo: 0001193805-19-000332 Size: 59 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Adma生物制品(ADMA)$ 8-K - Current report Filed: 2019-03-18 AccNo: 0001193805-19-000301 Size: 3 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Adma生物制品(ADMA)$ 8-K - Current report Filed: 2019-03-13 AccNo: 0001193805-19-000280 Size: 119 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Adma生物制品(ADMA)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-13 AccNo: 0001193805-19-000281 Size: 4 MB 网页链接
$Adma生物制品(ADMA)$ 8-K - Current report Filed: 2019-03-04 AccNo: 0001193805-19-000254 Size: 3 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Adma生物制品(ADMA)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-02-27 AccNo: 0001193805-19-000251 Size: 63 KB 网页链接
$Adma生物制品(ADMA)$ 8-K - Current report Filed: 2019-02-25 AccNo: 0001193805-19-000246 Size: 46 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Adma生物制品(ADMA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001085146-19-000734 Size: 57 KB 网页链接
$Adma生物制品(ADMA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001193125-19-040961 Size: 64 KB 网页链接
$Adma生物制品(ADMA)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-13 AccNo: 0000919574-19-001192 Size: 125 KB 网页链接